AGON by AOC upcoming Black Friday Cyber Monday holiday deals, up to 55% off from 11/21-12/02! Post this AOC AGON PRO AG274QZM 27" is a High-End Tournament Gaming Monitor featuring ULTRA-HIGH CLARITY with 2K Quad HD 2560x1440 resolution IPS panel for excellent visuals and superb colors, BLAZING FAST SPEED with a 240Hz refresh rate and rapid 1ms response time helps you hit moving targets with precision and get you ahead of the competition by milliseconds and PRECISION TO THE MAX with G-SYNC compatible VRR technology ensuring ultra-smooth, tear-free team fights for flawless skill shots and stutter-free loading times. Available at AMAZON: https://a.co/d/eoMauvw Was: $1,049.99, Now: $469.99 (55% off) AOC AGON PRO AG324UX 32" Gaming Monitor featuring ULTRA-HIGH CLARITY with 4K UHD 3840x2160 resolution IPS panel for excellent visuals and superb colors, BLAZING FAST SPEED with a 144Hz refresh rate, rapid 1ms response time, and AdaptiveSync help you hit moving targets with precision and get you ahead of the competition by milliseconds and IMPRESSIVE COLORS featuring VESA DisplayHDR 400 and 1.07 billion colors bring characters to life with rich details, diverse contrast, and wide color gamut (99.8% DCI-P3, 125% sRGB) for full immersion. Available at AMAZON: https://a.co/d/3W44geX Was: $799.99, Now: $378.99 (52% off) AOC AGON PRO AG276QZD2 27" OLED Tournament Gaming Monitor with Unbeatable speeds featuring a 240Hz refresh rate, 0.03ms... AGON by AOC
bookmaker design
。
B.C. Premier Eby says U.S. tariffs would be 'devastating' for forest industryMastercard Teams With Türkiye’s Dgpays to Promote Digital PaymentsWASHINGTON DC, UNITED STATES - MAY 16: Open AI's CEO Sam Altman testifies at an oversight hearing by ... [+] the Senate Subcommittee on Privacy. OpenAI's transformation from a nonprofit research laboratory established in 2015 to a pioneering force in artificial intelligence presents a fascinating case study in technological evolution, intellectual property, and organizational governance. The creator of ChatGPT has experienced a year of unprecedented challenges and changes, offering valuable insights into the broader AI industry's development. The lessons learned from OpenAI's challenges and adaptations in 2024 will likely influence the interplay amongst intellectual property, organizational model, and AI governance for years to come. The Current Challenges and Complexities The legal arena has become increasingly complex for OpenAI in 2024. The New York Times initiated significant legal action, filing a lawsuit against both OpenAI and Microsoft. The suit alleges that millions of Times articles were used without authorization in training AI models, raising fundamental questions about intellectual property rights in the digital age. This case has become a bellwether for how traditional copyright law applies to AI development. Others like The Intercept, New York Daily News, Chicago Tribune, and Denver Post, have also filed lawsuits against OpenAI for copyright infringement. The dispute extends beyond media organizations. Elon Musk's legal challenge against OpenAI has added another dimension to the company's legal battles. The lawsuit centers on OpenAI's transition from its original nonprofit structure, with Musk arguing this shift contradicts the organization's founding principles. OpenAI has defended its position , suggesting that Musk's actions might be influenced by his involvement in competing AI ventures, highlighting the increasingly competitive nature of the AI sector. The year has also marked a period of significant internal change at OpenAI. The company has experienced several high-profile departures , including co-founder Ilya Sutskever and chief technology officer Mira Murati and the controversy continues with other key resignations such as Greg Brockman (Co-Founder), John Schulman (Co-Founders), Bob McGrew (Chief Research Officer), Jan Leike (Engineer in AI Safety), and Barret Zoph (VP of Research). The departures have forced a broader discussions within the organization about its strategic direction and commitment to AI safety principles. In response to these concerns, OpenAI established a dedicated safety and security committee Industry-Wide Implications and Future Challenges OpenAI's experiences in 2024 illuminate several critical challenges facing the AI industry as a whole. Google’s Gmail Upgrade—Why You Need A New Email Address In 2025 Urgent New Gmail Security Warning For Billions As Attacks Continue FinCEN Extends Beneficial Ownership Information (BOI) Reporting Deadline The intersection of AI training and intellectual property rights has emerged as a central issue. The industry must navigate existing copyright frameworks while potentially helping to shape new regulations that balance innovation with rights protection. This includes addressing questions about fair use, compensation for content creators, and the establishment of clear guidelines for data usage in AI training. It has also created tension between profit-driven innovation and public benefit continues to challenge AI organizations. OpenAI's evolution from a nonprofit to a capped-profit model represents one approach to this balance, but questions persist about the optimal structure for AI companies serving both commercial and social interests. The implementation of effective safety measures while maintaining technological momentum remains a crucial challenge. The dissolution and subsequent reformation of safety teams at OpenAI demonstrates the ongoing debate about how best to approach AI safety governance. Additionally, the regulatory environment for AI continues to evolve. President-elect Trump's appointment of an AI czar represents one approach to government oversight, though the effectiveness of such measures remains to be seen. The industry faces the challenge of working with regulators to create frameworks that promote innovation while protecting public interests. Looking Forward: The Path Ahead As AI technology continues its rapid advancement, the need for guardrails, governance, government, and frameworks become increasingly critical, while answering key questions: The answers to these questions will begin to shape the future of not just OpenAI, but the entire AI industry. The company's experience serves as a valuable case study in navigating the complex intersection of technology, ethics, and business in the AI era. The pace of AI development continues to accelerate, making it essential for stakeholders across industry, government, and academia to collaborate effectively. As the industry moves forward, the lessons learned from OpenAI's challenges and adaptations in 2024 will likely influence AI development and governance for years to come. The pace of AI development continues to accelerate, making it essential for stakeholders across industry, government, and academia to collaborate effectively. Success will require careful consideration of competing interests, clear communication of objectives and concerns, and a commitment to responsible innovation. As the industry moves forward, the lessons learned from OpenAI's challenges and adaptations in 2024 will likely influence AI development and governance for years to come.
The United States on Wednesday imposed sanctions on four Pakistani entities for their alleged involvement in advancing the country's long-range missile programme. "In light of the continuing proliferation threat of Pakistan's long-range missile development, the United States is designating four entities for sanctions pursuant to Executive Order (E.O.) 13382, which targets proliferators of weapons of mass destruction and their means of delivery," read a statement issued by the State Department.? The move is the latest aimed at targeting Pakistan's long-range missile programme. Earlier, the US listed Chinese and Belarusian entities on charges of supplying equipment and material for Pakistan's long-range missile program. Pakistan at the time dismissed the allegations and questioned the double standards of the US. The entities that the US listed includes Pakistan's National Development Complex. The US claims Pakistan National Development Complex is responsible for Pakistan's ballistic missile program and has worked to acquire items to advance Pakistan's long-range ballistic missile program. The State Department alleged the National Development Complex (NDC), located in Islamabad, Pakistan, has worked to acquire items in furtherance of Pakistan's long-range ballistic missile program - including special vehicle chassis intended to be used as launch support equipment for ballistic missiles and missile testing equipment. "The United States assesses NDC is responsible for Pakistan's development of ballistic missiles, including the SHAHEEN-series ballistic missiles," it claimed. Other entities that were sanctioned are Affiliates International, Akhtar and Sons Private Limited, and Rockside Enterprise. These entities were accused of supplying equipment and missile?applicable items to Pakistan's ballistic missile program, including its long range-missile program. The State Department said these entities were being designated pursuant to E.O. 13382 Section 1(a)(ii) for having engaged, or attempted to engage, in activities or transactions that have materially contributed to, or pose a risk of materially contributing to, the proliferation of weapons of mass destruction or their means of delivery (including missiles capable of delivering such weapons), including any efforts to manufacture, acquire, possess, develop, transport, transfer, or use such items, by Pakistan.? The United States will continue to act against proliferation and associated procurement activities of concern, it added. Pakistan's long-range missile program has remained under the US spotlight for years. Islamabad has resisted the pressure and even attempts by Washington to limit the range of missiles. The latest move by the Biden administration comes just weeks before President-elect Trump takes charge of the White House. Hours after the US move, Pakistan reacted sharply to the move, rejecting the decision. "Pakistan considers the US decision to impose sanctions on NDC and three commercial entities as unfortunate and biased. Pakistan's strategic capabilities are meant to defend its sovereignty and preserve peace and stability in South Asia, " read a statement issued by the Foreign Office. It said the latest installment of sanctions defies the objective of peace and security by aiming to accentuate military asymmetries. Such policies have dangerous implications for strategic stability of our region and beyond. "Pakistan's strategic programme is a sacred trust bestowed by 240 million people upon its leadership. The sanctity of this trust, held in the highest esteem across the entire political spectrum, cannot be compromised," the statement said. "We also regret the imposition of sanctions on private commercial entities. Similar listings of commercial entities in the past were based on mere doubts and suspicion without any evidence whatsoever. While claiming strict adherence to non-proliferation norms, licensing requirement for advanced military technology to other countries have been waived off in the past." It further said such double standards and discriminatory practices not only undermine the credibility of non-proliferation regimes but also endanger regional and international peace and security. COMMENTS Comments are moderated and generally will be posted if they are on-topic and not abusive. For more information, please see our
Even with technology taking over much of our day-to-day lives, board games still offer quality entertainment that can’t be beaten. Of course, the popular board games of today are a far cry from the games your parents grew up playing. Board games are perfect for encouraging your family to work together or for bringing your group of friends around the table for an evening. If you’d like to start up a weekly game night, let this helpful list of the most popular board games be your guide. Utter Nonsense Ages 8+ This game will have every player rolling in stitches with each ridiculous phrase that’s uttered. Combine crazy accents and hilarious phrases to impress the Nonsense Judge and win the round. The player with the highest number of wins ultimately wins the game, but the true fun of this card game is listening to your fellow players trying to say some of the most entertaining phrases of all time. This game is perfect for game nights or parties. Speak Out Ages 8+ This hilarious game is perfect if you have teenagers or are hosting a party with all adults. To play, you insert a mouthpiece that alters the sound of your speech, making every word sound silly. Set the timer and read one of the phrases on the cards and try to help your teammate guess what you’re saying. Speak Out easily provides hours of fun that even grandparents will love. Escape Room in a Box Ages 13+ What’s the next best thing to trying to break out of a room? Escape Room in a Box, of course. This thrilling, immersive game involves solving 2D and 3D puzzles in order to prevent a mad scientist from turning you and your friends or family into werewolves. Work together to escape your fate and use Amazon Alexa to enhance the experience. Codenames Ages 14+ This fun strategy game is perfect for anyone with teenagers. Form two teams and select a spymaster on each team. Using clues, spymasters try to help their teammates find all 25 of the agents they’re in contact with, hopefully without selecting the other team’s agents or running into the deadly assassin. This innovative game offers a challenging and rewarding time working together. Harry Potter Clue Ages 9+ Excite your kids on game night with this modern twist on a classic. Play as six recognizable Hogwarts characters — Harry, Hermione, Ron, Luna, Ginny or Neville — to solve the mystery behind a fellow student’s disappearance. It’s up to you to figure out who attacked the student, what bewitching spell they used and where it occurred. Watch out for the Dark Mark, moving staircases and secret passages as you travel along in this magical family game. Pandemic Ages 8+ If you’ve ever wanted to save humanity from a deadly outbreak, you’ll love spending an hour playing Pandemic. You and your teammates must fight to contain four deadly diseases threatening the human race. Players must learn to work with their teammates to control outbreak hotspots and treat diseases. Win the game by curing all diseases without wiping out humanity first. Catan Ages 10+ This tactical 60-minute game will push your imagination to its limits as you embark on a journey across Catan. Acquire crucial resources as you travel, build roads, buildings, and cities, and be wary of the ruthless robber and other players halting you on your own road. Through careful trading and clever decisions, you can lead your travelers to victory in this role-playing game of limitless possibilities. Play again and again. Every game is different. Ticket to Ride Ages 8+ Train lovers will enjoy this innovative board game which has won numerous awards. This cross-country train adventure game mimics the concept of traveling around the world in 80 days. Collect train cars and claim railways across the country. Players earn the most points by establishing long train routes and connecting distant cities. Each game takes roughly 30 to 40 minutes to complete, and every adventure is different. 5 Second Rule Ages 10+ This quick-paced game gives each player five seconds to name items on a certain topic. Although the topics are objectively easy —“Name 3 Mountains,” “Name 3 Types of Hats” or “Name 3 Super Heroes,” the pressure of the time crunch is likely to put you on edge. Race the clock and remain composed to win this game. You can even make up your own topics if you prefer. Half the fun is just hearing what other people blurt out, whether it’s relevant to the topic or not. Prices listed reflect time and date of publication and are subject to change. Check out our Daily Deals for the best products at the best prices and sign up here to receive the BestReviews weekly newsletter full of shopping inspo and sales. BestReviews spends thousands of hours researching, analyzing and testing products to recommend the best picks for most consumers. BestReviews and its newspaper partners may earn a commission if you purchase a product through one of our links.Real Madrid forward Rodrygo reportedly down a lucrative offer from Manchester City in the summer to stay in Spain. Pep Guardiola 's side have all but surrendered their Premier League title given the club are in seventh place with 27 points, 12 fewer than first-placed Liverpool despite having played a game more than the Reds. The champions were beaten 2-1 by Aston Villa on Saturday afternoon, their ninth loss in their last 12 matches in all competitions. Phil Foden might have found the back of the net late on but City did not appear to be particularly threatening, with striker Erling Haaland looking an isolated figure up front. The Daily Mail claim that City tried to strengthen their attack in the summer, reporting that a significant offer was made to Rodrygo but that he ultimately turned it down despite seriously contemplating a switch to England. Much has been made of City's defensive weaknesses, and while the champions do look vulnerable during counter-attacks, Guardiola's side have only scored 14 goals in their past 12 fixtures in all competitions. Haaland's form has been alarming considering the Norwegian has only netted three times in his last 12 Premier League games, whereas he had scored 10 goals in his first five league games of 2024-25. Foden's goal against Villa was his first for City in the Premier League this season and just his fourth in 24 games for club and country. Rodrygo's Real Madrid have not been particularly strong this campaign, and he has often had to play on the right side of attack despite preferring to operate on the left, but has still managed to score five goals and produce three assists in 977 La Liga minutes. While Rodrygo would not have helped solve City's defensive issues, he would have undoubtedly offered the team a different option in the forward line, especially as his versatility and instinct in front of goal could have helped alleviate the burden on the likes Haaland. Guardiola has himself indicated that without the return of players such as Rodri from injury, and without reinforcements in January, City's poor form is likely to continue . Kevin De Bruyne is also out of contract at the end of the season, and there is a real possibility that fans could be seeing the last of the City legend in England. Additionally, other key figures such as Ederson and Kyle Walker have come under significant scrutiny for their poor performances of late, and it would seem that several areas of the squad may have to be addressed in the upcoming transfer windows. The threat of being punished by the Premier League for breaching the division's financial rules is also a cloud that continues to hang over the Citizens. Fans will hope that Rodrygo's reported rejection is an isolated case, and that the club are able to attract several new arrivals across the January and summer transfer windows.
FuriosaAI Ends 2024 on a High Note: Llama 3.1 Performance, SDK Release, Leadership Expansion
The Government has announced it is doubling funds to support workers and businesses affected by job losses at a giant Tata steel plant. Ministers said an extra £15 million will be made available for supply chain businesses and workers affected by changes at Tata’s Port Talbot site in south Wales. Welsh Secretary Jo Stevens said the move means a fund to support businesses across Wales heavily reliant on Tata steel will be increased to £30 million. She also announced that more businesses will be able to apply for the funds, and the value of individual grants is increasing to up to £250,000 for businesses to invest in equipment, property, technology. The Government said there has been “significant demand” on the existing funding, with almost 40 businesses employing 2,000 people having begun the application process. Grants worth millions of pounds are expected to be released in the new year. The increase in funding is in anticipation of more people leaving Tata in early 2025 through the company’s voluntary redundancy scheme. Ms Stevens said: “This Government is acting decisively to support workers and businesses in Port Talbot. “We are doubling the funding available to businesses and workers and widening access to grants to ensure we support as many people as possible. “In just four months we have announced more than £40 million in investment. We said we would back workers and businesses affected by the transition at Port Talbot and we are doing exactly that. “While this remains a very difficult time for Tata workers, their families and the community, we are determined to support workers and businesses in our Welsh steel industry, whatever happens.”2seventy bio: All In On Abecma Multiple Myeloma Treatment
NEW YORK (AP) — Sean “Diddy” Combs was denied bail on Wednesday as he awaits a May sex trafficking trial by a judge who cited evidence showing him to be a serious risk of witness tampering and proof that he has violated regulations in jail. U.S. District Judge Arun Subramanian made the decision in a written ruling following a bail hearing last week, when lawyers for the hip-hop mogul argued that a $50 million bail package they proposed would be sufficient to ensure Combs doesn’t flee and doesn’t try to intimidate prospective trial witnesses. Two other judges previously had been persuaded by prosecutors’ arguments that the Bad Boy Records founder was a danger to the community if he is not behind bars. Lawyers did not immediately respond to messages seeking comment on the decision. Combs, 55, has pleaded not guilty to charges that he coerced and abused women for years, aided by associates and employees. An indictment alleges that he silenced victims through blackmail and violence, including kidnapping, arson and physical beatings. A federal appeals court judge last month denied Combs’ immediate release while a three-judge panel of the 2nd U.S. Circuit Court of Appeals in Manhattan considers his bail request. Prosecutors have insisted that no bail conditions would be sufficient to protect the public and prevent the “I'll Be Missing You” singer from fleeing. They say that even in a federal lockup in Brooklyn, Combs has orchestrated social media campaigns designed to influence prospective jurors and tried to publicly leak materials he thinks can help his case. They say he also has contacted potential witnesses through third parties. Lawyers for Combs say any alleged sexual abuse described in the indictment occurred during consensual relations between adults and that new evidence refutes allegations that Combs used his “power and prestige” to induce female victims into drugged-up, elaborately produced sexual performances with male sex workers known as “Freak Offs.” Larry Neumeister, The Associated PressAustralian Senate begins debate on world-first social media ban for children under 16
Ukrainian girls’ team finds hockey haven at Wickenheiser festivalThe main contributors to the latest contraction included a 1.1% decline in retail. Photo: RNZ By Gyles Beckford of RNZ New Zealand's economy was in a deeper than expected recession in the middle of the year, with widespread contraction across many sectors. Stats NZ data shows gross domestic product, the broad measure of economic growth, fell 1% in the three months ended September, to be 1.5% lower than a year ago. Significant revisions to previous figures resulted in a fall of 1.1% in the June quarter, meeting the definition of technical recession. These were the biggest quarterly falls since late 2021 at the height of the Covid-19 pandemic and lockdowns, but excluding those the six monthly fall was the largest since mid-1991. However, previous negative readings for 2022/23 have largely disappeared. Stats NZ said extra data had shown a different performance of the economy. "The data incorporated this year shows stronger growth over the last year, followed by two significant falls in the latest quarters," spokesperson Jason Attewell said. Short, sharp recession The big falls in the June and September quarters were the biggest quarterly drops since late 2021 at the height of the pandemic and lockdowns. But excluding those the six-monthly fall was the largest since mid-1991. The main contributors to the latest contraction were a 2.6% fall in manufacturing, 3.7% in electricity and gas, 2.8% drop in construction and 1.1% decline in retail. The fall in manufacturing in part reflected the energy crunch in mid-winter which forced some businesses to reduce or halt production. The growth spots were agriculture on the back of the strong dairy production, information and technology, and rental and real estate industries. Individual shares of the economy shrank again, by 1.2% during the quarter, the eighth consecutive quarterly fall. The latest GDP reading is expected to be the low point of the recent economic cycle, with falling interest rates expected to give a spark to household spending and business investment. Forecasts are for tepid but positive growth from the end of this year picking up pace in the second half of next year to average 2-3% over the next few years. New Zealand's economic activity was the weakest of all its major trading partners.
It looked like a recipe for disaster. So, when his country's swimmers were being accused of doping earlier this year, one Chinese official cooked up something fast. He blamed it on contaminated noodles. In fact, he argued, it could have been a culinary conspiracy concocted by criminals, whose actions led to the cooking wine used to prepare the noodles being laced with a banned heart drug that found its way into an athlete's system. This theory was spelled out to international anti-doping officials during a meeting and, after weeks of wrangling, finally made it into the thousands of pages of data handed over to the lawyer who investigated the case involving 23 Chinese swimmers who had tested positive for that same drug. The attorney, appointed by the World Anti-Doping Agency, refused to consider that scenario as he sifted through the evidence. In spelling out his reasoning, lawyer Eric Cottier paid heed to the half-baked nature of the theory. “The Investigator considers this scenario, which he has described in the conditional tense, to be possible, no less, no more,” Cottier wrote. Even without the contaminated-noodles theory, Cottier found problems with the way WADA and the Chinese handled the case but ultimately determined WADA had acted reasonably in not appealing China's conclusion that its athletes had been inadvertently contaminated. Critics of the way the China case was handled can't help but wonder if a wider exploration of the noodle theory, details of which were discovered by The Associated Press via notes and emails from after the meeting where it was delivered, might have lent a different flavor to Cottier's conclusions. “There are more story twists to the ways the Chinese explain the TMZ case than a James Bond movie,” said Rob Koehler, the director general of the advocacy group Global Athlete. "And all of it is complete fiction.” In April, reporting from the New York Times and the German broadcaster ARD revealed that the 23 Chinese swimmers had tested positive for the banned heart medication trimetazidine, also known as TMZ. China's anti-doping agency determined the athletes had been contaminated, and so, did not sanction them. WADA accepted that explanation , did not press the case further, and China was never made to deliver a public notice about the “no-fault findings,” as is often seen in similar cases. The stock explanation for the contamination was that traces of TMZ were found in the kitchen of a hotel where the swimmers were staying. In his 58-page report , Cottier relayed some suspicions about the feasibility of that chain of events — noting that WADA's chief scientist “saw no other solution than to accept it, even if he continued to have doubts about the reality of contamination as described by the Chinese authorities.” But without evidence to support pursuing the case, and with the chance of winning an appeal at almost nil, Cottier determined WADA's “decision not to appeal appears indisputably reasonable.” A mystery remained: How did those traces of TMZ get into the kitchen? Shortly after the doping positives were revealed, the Institute of National Anti-Doping Organizations held a meeting on April 30 where it heard from the leader of China's agency, Li Zhiquan. Li's presentation was mostly filled with the same talking points that have been delivered throughout the saga — that the positive tests resulted from contamination from the kitchen. But he expanded on one way the kitchen might have become contaminated, harkening to another case in China involving a low-level TMZ positive. A pharmaceutical factory, he explained, had used industrial alcohol in the distillation process for producing TMZ. The industrial alcohol laced with the drug “then entered the market through illegal channels,” he said. The alcohol "was re-used by the perpetrators to process and produce cooking wine, which is an important seasoning used locally to make beef noodles,” Li said. “The contaminated beef noodles were consumed by that athlete, resulting in an extremely low concentration of TMZ in the positive sample. "The wrongdoers involved have been brought to justice.” This new information raised eyebrows among the anti-doping leaders listening to Li's report. So much so that over the next month, several emails ensued to make sure the details about the noodles and wine made their way to WADA lawyers, who could then pass it onto Cottier. Eventually, Li did pass on the information to WADA general counsel Ross Wenzel and, just to be sure, one of the anti-doping leaders forwarded it, as well, according to the emails seen by the AP. All this came with Li's request that the noodles story be kept confidential. Turns out, it made it into Cottier's report, though he took the information with a grain of salt. “Indeed, giving it more attention would have required it to be documented, then scientifically verified and validated,” he wrote. Neither Wenzel nor officials at the Chinese anti-doping agency returned messages from AP asking about the noodles conspiracy and the other athlete who Li suggested had been contaminated by them. Meanwhile, 11 of the swimmers who originally tested positive competed at the Paris Games earlier this year in a meet held under the cloud of the Chinese doping case. Though WADA considers the case closed, Koehler and others point to situations like this as one of many reasons that an investigation by someone other than Cottier, who was hired by WADA, is still needed. “It gives the appearance that people are just making things up as they go along on this, and hoping the story just goes away," Koehler said. “Which clearly it has not.” AP Olympics: https://apnews.com/hub/2024-paris-olympic-games
Liberal GST holiday expected to pass soon as government introduces solo billSANTA CLARA, Calif. , Dec. 19, 2024 /PRNewswire/ -- FuriosaAI , an emerging leader in AI semiconductor solutions, is closing out the year with rapid technical and customer progress with its second-generation chip, RNGD (pronounced 'Renegade'). The recently announced AI solution has achieved compelling performance metrics in real-world enterprise deployments meeting the demand for inference with advanced large language and multimodal models. The new performance benchmarks showcase RNGD's ability to meet industry-leading throughput demands for Llama 3.1 models, including the 8B and 70B variants, with additional optimizations already in progress. The company also announced key software features that bring advanced optimization for customers currently sampling RNGD hardware in their production environments. These achievements represent the first phase of Furiosa's vision for AI infrastructure that overcomes the inherent limitations of GPUs. RNGD delivers winning throughput metrics with Llama 3.1 8B and 70B : Building on the AI-native Tensor Contraction Processor (TCP) architecture of RNGD , Furiosa is redefining real-world AI deployments, delivering unmatched performance, programmability, and power efficiency. Furiosa's RNGD recently achieved a throughput of 3,200–3,300 Tokens per Second (TPS) when running the LLaMA 3.1- 8B model. In single-user scenarios, RNGD consistently delivers 40–60 TPS performance. Additionally, RNGD demonstrates exceptional power efficiency, consuming 181W per card, with further optimization efforts underway. Rather than excessively boosting per-user performance, the company aims to maintain performance levels exceeding typical text-reading speeds (10–20 TPS or higher) while optimizing for multi-user environments and achieving a balanced performance approach. Furiosa is advancing the performance and efficiency of the LLaMA 3.1- 70B model. With just two RNGD cards, LLaMA 3.1- 70B can be executed effectively. Currently, a single server supports up to 100 concurrent user queries, with ongoing optimizations aiming to achieve 8,000 TPS per server when equipped with 8 RNGD cards. With the release of SDK v2024.3.0, Furiosa will expand the range of preloaded models. The SDK will also include support for tensor parallelism, enabling seamless processing across multiple elements without requiring model modifications, and a torch.compile, providing the foundation for executing customized models. Integration with HuggingFace Optimum will further empower customers to leverage a broader variety of models. Advanced optimization tools delivered to early RNGD customers: Building on these milestones, domestic and global enterprise customers are conducting tests with Furiosa to find a more efficient solution for scaling the inference of their self-developed models, compared to their existing setup. Their objective is to manage TCO effectively as they prepare for large-scale AI adoption. Furiosa plans to provide a high-quality AI development environment through a powerful and user-friendly SDK optimized for RNGD. The SDK v2024.1.0, currently available through the Early Access Program (EAP), is designed to handle high-performance processing of multiple LLM serving requests. It incorporates optimization techniques such as PagedAttention, Block KV Cache, and Continuous Batching, while also supporting various token sampling methods, including Greedy, Beam Search, and Top-k/p. These features allow developers to seamlessly create AI services customized to meet a wide range of requirements. The SDK and online sample will be available after the release of v2024.3.0. Furiosa remains committed to delivering the most sustainable AI deployment solutions through rigorous optimization at an unprecedented pace. "With RNGD now in customers' hands, we are accelerating the next generation of frontier LLMs to unlock emerging Agentic AI applications—bringing advanced reasoning capabilities to enterprise verticals, all at dramatically lower costs," said June Paik , Co-Founder and CEO of FuriosaAI. Furiosa Expands Global Footprint with Strategic Leadership Appointment Furiosa is scaling production and expanding its leadership team with the appointment of Alex Liu as Senior Vice President of Product and Business. A Technology Emmy Award winner and co-founder of NETINT Technologies, Alex brings over 20 years of expertise in startup management, technology innovation, and strategic leadership. At NETINT, he spearheaded groundbreaking achievements, including the development of the world's first VPU SoC, setting new industry benchmarks and securing the prestigious 2024 Technology Emmy Award. At Furiosa, Alex will lead global product management, go-to-market strategies, and partnerships to drive innovation and align the company's AI-native technologies with a vision to empower the development of planet-scale AI infrastructure. RNGD is currently sampling with customers, and mass production will ramp up in partnership with TSMC for 2025 availability. To learn more about Furiosa, please visit https://furiosa.ai/ . About FuriosaAI FuriosaAI is a semiconductor company dedicated to creating sustainable AI computing solutions that make powerful AI accessible to all. With its innovative Tensor Contraction Processor architecture, FuriosaAI is revolutionizing the AI hardware landscape, offering unparalleled efficiency and programmability for the most demanding AI workloads. For more information, please visit https://furiosa.ai/ . View original content to download multimedia: https://www.prnewswire.com/news-releases/furiosaai-ends-2024-on-a-high-note-llama-3-1-performance-sdk-release-leadership-expansion-302336756.html SOURCE FuriosaAI
Over the past two days, President-elect Donald Trump has made clear that he has designs for American territorial expansion, declaring that the United States has both security concerns and commercial interests that can best be addressed by bringing the Panama Canal and Greenland under American control or outright ownership. Trump’s tone has had none of the trolling jocularity that surrounded his repeated suggestions in recent weeks that Canada should become America’s “51st state,” including his social media references to the country’s beleaguered prime minister as “Governor Justin Trudeau.” Instead, while naming a new ambassador to Denmark — which controls Greenland’s foreign and defense affairs — Trump made clear on Sunday that his first-term offer to buy the landmass could, in the coming term, become a deal the Danes cannot refuse. He appears to covet Greenland both for its strategic location at a time when the melting of Arctic ice is opening new commercial and naval competition and for its reserves of rare earth minerals needed for advanced technology. “For purposes of National Security and Freedom throughout the World,” Trump wrote on social media, “the United States of America feels that the ownership and control of Greenland is an absolute necessity.” On Saturday evening, he had accused Panama of price-gouging American ships traversing the canal, and suggested that unless that changed, he would abandon the Jimmy Carter-era treaty that returned all control of the canal zone to Panama. “The fees being charged by Panama are ridiculous,” he wrote, just before an increase in the charges scheduled for Jan. 1. “This complete ‘rip-off’ of our country will immediately stop.” He went on to express worry that the canal could fall into the “wrong hands,” an apparent reference to China, the second-largest user of the canal. A Hong Kong-based firm controls two ports near the canal, but China has no control over the canal itself. Not surprisingly, the government of Greenland immediately rejected Trump’s demands, as it did in 2019, when he first floated the idea. “Greenland is ours,” Prime Minister Mute B. Egede said in a statement. “We are not for sale and will never be for sale. We must not lose our long struggle for freedom.” The Danish prime minister’s office was more circumspect, writing in a statement that the government was “looking forward to working with the new administration” and offering no further comment on Trump’s remarks. After Trump brought up the Panama Canal again in a speech on Sunday, Panama’s president, José Raúl Mulino, said in a video that “every square meter of the Panama Canal and its adjacent zones is part of Panama, and it will continue to be.” He added: “Our country’s sovereignty and independence are not negotiable.” But the president-elect’s statements — and the not-so-subtle threats behind them — were another reminder that his version of “America First” is not an isolationist creed. His aggressive interpretation of the phrase evokes the expansionism, or colonialism, of President Theodore Roosevelt, who cemented control of the Philippines after the Spanish-American War. And it reflects the instincts of a real estate developer who suddenly has the power of the world’s largest military to back up his negotiating strategy. Trump has often suggested that he does not always see the sovereignty of other nations’ borders as sacrosanct. When Russia invaded Ukraine, his first response was not a condemnation of the blatant land grab, but rather the observation that President Vladimir Putin’s move was an act of “genius.” Even now, as Trump seeks a deal to end the war in Ukraine, he has never said that the country’s borders must be restored, a key demand of the United States and NATO — he has only promised a “deal” to end the fighting. In the cases of Greenland and Panama, both commercial and national security interests are at play. Trump’s desire for Greenland was made explicit in the first term, when a wealthy New York friend of his, Ronald S. Lauder, the New York cosmetics heir, put the idea in his head. In the Trump White House in 2019, the National Security Council was suddenly delving into the details of how the United States would pull off a land acquisition of that size. Trump kept pressing the point with Denmark, which consistently rebuffed him. Trump was not the first president to make the case: Harry S. Truman wanted to buy Greenland after World War II, as part of a Cold War strategy for boxing out Soviet forces. Trump can make a parallel argument, especially as Russia, China and the United States jockey for control of Arctic routes for commercial shipping and naval assets. Arctic experts did not dismiss Trump’s Greenland bid as a joke. “Not that many people are laughing about it now,” said Marc Jacobsen, an associate professor at the Royal Danish Defense College in Denmark who focuses on Arctic security. Jacobsen noted that the reaction in Denmark to Trump’s latest bid had been one of fury (one Danish politician called it “an unusually strange way to be an ally”). But, he said, Greenlanders — who have long sought independence — may seek to use Trump’s interest as an opportunity to further strengthen economic ties with the United States. Since 2009, Greenland has had the right to declare its independence, but the vast territory of about 56,000 people is still heavily dependent on Denmark and has never chosen to pursue that path. Trump’s interest could give Greenland an opening for more U.S. investments, including in tourism or rare earth mining, he said. “Was it crazy when the U.S. acquired Alaska? Was it crazy when the U.S. built the Panama Canal?” asked Sherri Goodman, a former Pentagon official and a senior fellow with the Wilson Center Polar Institute, a Washington-based think tank. Goodman, whose book “Threat Multiplier: Climate, Military Leadership, and the Fight for Global Security” centers in part on the Arctic, said the United States did have a strong interest in ensuring that China in particular does not develop a strong presence in Greenland. China’s ambitions in the Arctic have grown, and in 2018 it laid out plans to build infrastructure and develop shipping lanes opened by climate change. Goodman said the United States should continue to prevent China from gaining a foothold in the doorstep to North America, but said Greenlanders must decide their own fate. “We want to have all those territories proximate to our own mainland territory to protect us and also to prevent an adversary from using it to our strategic disadvantage,” Goodman said. “On the other hand, there is international law and international order and sovereignty, and Greenland is still a part of Denmark.” When it comes to Panama, Trump may also hold a distant personal grudge. In 2018, Panamanian police officers ousted the Trump Organization from the Trump International Hotel in Panama City after a protracted legal battle between the president-elect’s family and the majority owner of the property. The Trump name subsequently came down. The company had held a contract to manage the property. David L. Goldwyn, who served at the State Department under Presidents Bill Clinton and Barack Obama, noted that Greenland has tremendous undeveloped natural resources, including more than 43 of the 50 so-called critical rare earth elements used to make electric vehicles, wind turbines and other clean technology. “Certainly if Greenland chose to develop these resources, it would provide a significant alternative to China, although it is China’s capacity to process those minerals which gives it its current advantage,” he said. But Goldwyn said that in addition to Denmark’s sovereignty, Trump might find that Greenland’s Indigenous communities do not want mining and resource extraction as much as he does. “It is highly unlikely resource extraction could be forced on an unwilling population,” he said. “A more fruitful path might be to collaborate with the Danish government and Greenland’s population on ways to safely and sustainably develop those resources.” This article originally appeared in The New York Times . © 2024 The New York Times CompanyThe dynamics of the germ cell tumors market are anticipated to change in the coming years owing to the approval of specialized therapies for GCT and anticipated greater patients getting access to treatment across the world. Some key players such as Exelixis (Cabozantinib), Daiichi Sankyo (DS-9606), and HiFiBiO Therapeutics (HFB200301) are investigating their candidates to treat GCT in the 7MM. LAS VEGAS , Dec. 18, 2024 /PRNewswire/ -- DelveInsight's Germ Cell Tumors Market Insights report includes a comprehensive understanding of current treatment practices, germ cell tumors emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany , France , Italy , and Spain ) and the United Kingdom , and Japan]. Key Takeaways from the Germ Cell Tumors Market Report According to DelveInsight's analysis, the market size for germ cell tumors in the 7MM is expected to reach ~ USD 630 million by 2034. Cabozantinib is expected to garner the largest market share of USD 129 million in the US by 2034, followed closely by DS-9606a , with a market share of USD 63 million . The incidence of GCT is around 26,000 cases in the 7MM in 2023. Leading germ cell tumors companies such as AstraZeneca, Exelixis, Pfizer, Xencor, Inc., Daiichi Sankyo, HiFiBiO Therapeutics, and others are developing novel germ cell tumors drugs that can be available in the germ cell tumors market in the coming years. The promising germ cell tumor therapies in the pipeline include Cabozantinib, Talazoparib, XmAb541, DS-9606a, and HFB200301, among others. Discover which therapies are expected to grab the major Germ Cell Tumors market share @ Germ Cell Tumors Market Report Germ Cell Tumors Overview Germ cell tumors are a rare type of growth that originates from germ cells, the cells responsible for developing into sperm in males and eggs in females. These tumors can be benign or malignant and often develop in the gonads, but they can also arise in other areas of the body, such as the abdomen, chest, or brain. The exact cause of germ cell tumors is not always clear, but genetic and environmental factors may play a role. Some known risk factors include abnormal development of the gonads, family history of similar conditions, and certain inherited syndromes. Germ cell tumor symptoms depend on the tumor's location and size. Common signs include swelling or a mass in the affected area, abdominal or chest pain, difficulty breathing (in cases of tumors in the chest), or hormonal changes. In some cases, the tumors may cause symptoms such as fatigue or unexplained weight loss. Germ cell tumor diagnosis typically involves a combination of imaging studies, blood tests to measure tumor markers like alpha-fetoprotein (AFP) or beta-human chorionic gonadotropin (β-hCG), and biopsy or surgical removal of the tumor to determine its nature. Early detection and treatment are crucial for improving outcomes, with therapies including surgery, chemotherapy, radiation, or a combination of these approaches. Germ Cell Tumors Epidemiology Segmentation The germ cell tumors epidemiology section provides insights into the historical and current germ cell tumors patient pool and forecasted trends for the 7MM. It helps recognize the causes of current and forecasted patient trends by exploring numerous studies and views of key opinion leaders. The germ cell tumors market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into: Total Incident Cases of GCT Type-specific Incident Cases of GCT Sub-type specific Cases of Gonadal GCT Age-specific Cases of GCT Gender-specific Incident Cases of GCTs Total Incident Cases of GCTs by Stage Total Treatable Cases of GCT Line-wise Treatable Cases of GCT Germ Cell Tumors Treatment Market The treatment approach for germ cell tumors depends on the tumor type, whether ovarian or testicular. Surgery, followed by chemotherapy and sometimes radiation therapy, forms the cornerstone of GCT management. For recurrent testicular cancer, a chemotherapy combination of ifosfamide (Ifex), paclitaxel (Taxol), and cisplatin (Platinol) has proven highly effective. Notably, testicular cancers were among the first cancers successfully treated with radiation or chemotherapy. Over 80% of patients with metastatic germ cell tumors achieve a cure with cisplatin-based chemotherapy, typically the bleomycin, etoposide, and cisplatin (BEP) regimen, combined with surgery for residual disease. However, only about 25% of patients who relapse attain long-term survival after second-line cisplatin-based therapy, often using the vinblastine, ifosfamide, and cisplatin (VeIP) regimen. BEP remains the standard first-line chemotherapy for GCTs, effective in both seminomas and nonseminomas. This regimen capitalizes on cisplatin's DNA-damaging properties, etoposide's inhibition of DNA synthesis, and bleomycin's ability to induce DNA strand breaks, resulting in high cure rates. Treatment typically involves 3 to 4 cycles, tailored to disease stage and risk factors. Advancements in surgical techniques, rising incidence rates, and improved post-surgical outcomes have increased the demand for surgical interventions, driving growth in the broader GCT treatment market. To know more about germ cell tumor treatment guidelines, visit @ Germ Cell Tumors Management Germ Cell Tumors Pipeline Therapies and Key Companies Durvalumab + Tremelimumab: AstraZeneca Cabozantinib: Exelixis Talazoparib: Pfizer XmAb541: Xencor, Inc. DS-9606a: Daiichi Sankyo HFB200301: HiFiBiO Therapeutics Discover more about germ cell tumor drugs in development @ Germ Cell Tumors Clinical Trials Germ Cell Tumors Market Dynamics The germ cell tumors market dynamics are expected to change in the coming years. Platinum-based chemotherapy , such as the BEP regimen, is highly effective in treating both early and advanced-stage germ cell tumors, while surgical interventions like orchiectomy or oophorectomy also contribute significantly to successful outcomes. Biomarkers such as AFP, hCG, and LDH play a crucial role in diagnosis, staging, and monitoring treatment response, facilitating enhanced clinical decision-making and personalized care. Ongoing research into the genetic and molecular drivers of GCTs holds promise for developing highly effective, less toxic therapies, particularly for refractory or relapsed cases. Furthermore, identifying and validating new biomarkers could improve diagnosis, risk stratification, and relapse detection , advancing personalized treatment approaches for patients, including those with non-secretory tumors. Furthermore, potential therapies are being investigated for the treatment of germ cell tumors, and it is safe to predict that the treatment space will significantly impact the germ cell tumors market during the forecast period. Moreover, the anticipated introduction of emerging therapies with improved efficacy and a further improvement in the diagnosis rate are expected to drive the growth of the germ cell tumors market in the 7MM. However several factors may impede the growth of the germ cell tumors market. Platinum-based chemotherapy is highly effective but is associated with significant acute toxicities , such as nephrotoxicity and ototoxicity, as well as long-term effects like secondary malignancies, which can severely impact the quality of life, particularly for young survivors. Additionally, approximately 10–15% of patients develop resistance to first-line therapies , leaving them with few effective options, as salvage treatments are often toxic and have limited success rates. The emergence of resistance to platinum-based chemotherapy, especially in advanced or metastatic cases, poses a significant challenge, threatening the high cure rates associated with GCTs . Furthermore, the cost of advanced therapies , including novel drugs and long-term survivorship care, places a substantial financial burden on patients and healthcare systems, potentially limiting access to effective treatments. Moreover, germ cell tumor treatment poses a significant economic burden and disrupts patients' overall well-being and QOL. Furthermore, germ cell tumors market growth may be offset by failures and discontinuation of emerging therapies , unaffordable pricing , market access and reimbursement issues , and a shortage of healthcare specialists . In addition, the undiagnosed, unreported cases and the unawareness about the disease may also impact germ cell tumors market growth. Scope of the Germ Cell Tumors Market Report Therapeutic Assessment: Germ Cell Tumors current marketed and emerging therapies Germ Cell Tumors Market Dynamics: Key Market Forecast Assumptions of Emerging Germ Cell Tumors Drugs and Market Outlook Competitive Intelligence Analysis: SWOT analysis and Market entry strategies Unmet Needs, KOL's views, Analyst's views, Germ Cell Tumors Market Access and Reimbursement Download the report to understand which factors are driving germ cell tumors market trends @ Germ Cell Tumors Market Trends Table of Contents Related Reports Non-small Cell Lung Cancer Market Non-small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key NSCLC companies, including EMD Serono, Merck, Cellular Biomedicine Group, Inc., Celgene, CellSight Technologies, Inc., BeyondSpring Pharmaceuticals Inc., J Ints Bio, Forward Pharmaceuticals Co., Ltd., AstraZeneca, Bristol-Myers Squibb, Teligene US, Rain Oncology Inc, ReHeva Biosciences, Inc., Amgen, Novartis, RedCloud Bio, Parexel, Vitrac Therapeutics, LLC, Mythic Therapeutics, Instil Bio, Mirati Therapeutics Inc., Daiichi Sankyo, Inc., AstraZeneca, Precision Biologics, Inc, Promontory Therapeutics Inc., Palobiofarma SL, Regeneron Pharmaceuticals, Revolution Medicines, Inc., Cullinan Oncology, LLC, Iovance Biotherapeutics, Inc., Innate Pharma , among others. Non-small Cell Lung Cancer Pipeline Non-small Cell Lung Cancer Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key NSCLC companies, including BridgeBio Pharma, Daiichi Sankyo, EMD Serono, Merck, BridgeBio Pharma, Abbvie, Pfizer, Eli Lilly and Company BioNTech SE, Shenzhen TargetRx, Taiho Pharmaceutical, Chong Kun Dang , Bristol Myers Squibb, Innovent Biologics, Xuanzhu Biopharmaceutical, Bayer, GeneScience Pharmaceuticals, InventisBio, Apollomics, Imugene, Ono Pharmaceutical, Pierre Fabre , Jiangsu Hengrui Medicine Co., Bristol-Myers Squibb, Surface Oncology, Inhibrx, Sinocelltech, Mirati Therapeutics, REVOLUTION Medicines, Yong Shun Technology Development, Iovance Biotherapeutics, Galecto Biotech, among others. Small Cell Lung Cancer Market Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key advanced small cell lung cancer companies, including Ascentage Pharma, Merck & Co, AstraZeneca, Advenchen Laboratories, Advanced Accelerator Applications, Trillium Therapeutics, Wigen Biomedicine, Linton Pharm , Carrick Therapeutics, among others. Small-cell Lung Cancer Pipeline Small-cell Lung Cancer Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key small-cell lung cancer companies, including Ascentage Pharma, Merck & Co, AstraZeneca, Advenchen Laboratories, GlaxoSmithKline, Advanced Accelerator Applications, Trillium Therapeutics, Vernalis, Oncoceutics, NewBio Therapeutics, Wigen Biomedicine, Linton Pharm , Carrick Therapeutics, Xencor, Jiangsu HengRui Medicine, Aileron Therapeutics, Roche, Ipsen, Celgene, Lee's Pharmaceutical Limited, AbbVie, G1 Therapeutics, Chipscreen Biosciences, Luye Pharma Group, Shanghai Henlius Biotech, CSPC ZhongQi Pharmaceutical Technology, Impact Therapeutics, among others. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve . Contact Us Shruti Thakur [email protected] +14699457679 www.delveinsight.com Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg SOURCE DelveInsight Business Research, LLPNone
CANTON, Ga., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the highly anticipated release of new home sites at Aurora Ridge at Great Sky, a new community of luxury homes and future onsite amenities in Cherokee County, Georgia. Home buyers are invited to visit the Toll Brothers Sales Center, located at 1001 Winding Branch Drive in Canton, to tour the professionally decorated model home and learn more about the available home sites in the community. Aurora Ridge at Great Sky is a premier master-planned community offering two collections of two-story single-family homes priced from the low $500,000s. Homes in the Heritage and Cottage collections feature open floor plans ranging from 2,618 to 3,599+ square feet with two-car garages, home offices, and indoor/outdoor living features. The new home site releases offer basement options and a choice of locations with community views. Homeowners in Aurora Ridge at Great Sky will enjoy an amenity-rich resort lifestyle and convenient location along Interstate 575 and Georgia State Route 20. Future onsite amenities include a community clubhouse with a full-time Lifestyle Director; three swimming pools with a splash pad and water slide; pickleball, tennis, and basketball courts; and a nature trail featuring lakes and streams. "Nestled among the rolling green hills and overlooking the tranquil Hickory Log Creek Reservoir, Aurora Ridge at Great Sky is a gateway to an idyllic lifestyle in Canton, Georgia,” said Eric White, Division President of Toll Brothers in Georgia. "This community offers spacious single-family residences and luxurious amenities, set against a breathtaking natural backdrop. We invite home shoppers to visit us to learn more about the new home sites and tour model home to get inspired by the unrivaled personalization options available through our Design Studio experience.” Home buyers will experience one-stop shopping at the Toll Brothers Design Studio . The state-of-the-art Design Studio allows home buyers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants. For more information on Aurora Ridge at Great Sky and other Toll Brothers communities throughout Georgia, call 888-686-5542 or visit TollBrothers.com/GA . About Toll Brothers Toll Brothers, Inc., a Fortune 500 Company, is the nation's leading builder of luxury homes. The Company was founded 57 years ago in 1967 and became a public company in 1986. Its common stock is listed on the New York Stock Exchange under the symbol "TOL.” The Company serves first-time, move-up, empty-nester, active-adult, and second-home buyers, as well as urban and suburban renters. Toll Brothers builds in over 60 markets in 24 states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Indiana, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New York, North Carolina, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, and Washington, as well as in the District of Columbia. The Company operates its own architectural, engineering, mortgage, title, land development, smart home technology, and landscape subsidiaries. The Company also develops master-planned and golf course communities as well as operates its own lumber distribution, house component assembly, and manufacturing operations. In 2024, Toll Brothers marked 10 years in a row being named to the Fortune World's Most Admired CompaniesTM list and the Company's Chairman and CEO Douglas C. Yearley, Jr. was named one of 25 Top CEOs by Barron's magazine. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit TollBrothers.com . From Fortune, ©2024 Fortune Media IP Limited. All rights reserved. Used under license. Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations & Social Media | 215-938-8169 | [email protected] Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/431d7d04-9866-48af-aaca-d7fed87538e1 https://www.globenewswire.com/NewsRoom/AttachmentNg/e0fb70b6-fa4a-4a0b-bc3c-aba8cf07e24d https://www.globenewswire.com/NewsRoom/AttachmentNg/3bf24a3a-d15f-487d-a185-29ac58e953c6 Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)India’s bilateral trade with ASEAN sees 5.2 pc growth at $73 billion in April-Oct